Overexpression of SALL4 in lung cancer and its importance in cell proliferation

Daisuke Kobayashi1, Kageaki Kuribayashi, Maki Tanaka

  • 1Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.

Oncology Reports
|July 5, 2011
PubMed

Insights

SALL4 mRNA is overexpressed in lung cancer, showing high sensitivity and specificity for early diagnosis. Inhibiting SALL4 significantly halts lung cancer cell growth, suggesting its potential as a diagnostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Limited availability of sensitive and specific biomarkers for early lung cancer diagnosis.
  • SALL4, a transcription factor crucial for embryonic development and stem cell self-renewal, has not been previously investigated in lung cancer.

Purpose of the Study:

  • To investigate SALL4 mRNA as a potential diagnostic biomarker for lung cancer.
  • To explore the functional role of SALL4 in lung cancer cell proliferation.

Main Methods:

  • Quantitative analysis of SALL4 mRNA expression in cancerous and noncancerous lung tissues.
  • Receiver Operating Characteristic (ROC) curve analysis to determine diagnostic accuracy.
  • Analysis of SALL4 mRNA levels in paired tumor and adjacent non-tumor tissues.
  • Small interfering RNA (siRNA) mediated knockdown of SALL4 in lung cancer cells (SBC-1).
  • Cell cycle analysis to assess the impact of SALL4 inhibition on cell proliferation.

Main Results:

  • SALL4 mRNA was found to be overexpressed in lung cancer tissues.
  • SALL4 mRNA demonstrated high diagnostic sensitivity (85.1%) and specificity (92.9%) for lung cancer.
  • Elevated SALL4 mRNA levels (>2-fold) were observed in 93% of paired tumor samples.
  • High SALL4 mRNA expression was consistent across early (Stage IA) and advanced lung cancer stages.
  • siRNA-induced SALL4 knockdown resulted in significant growth inhibition of SBC-1 lung cancer cells.
  • SALL4 inhibition led to cell cycle arrest at the G1/early S phase.

Conclusions:

  • SALL4 mRNA overexpression is a significant finding in lung cancer, suggesting its potential as a novel diagnostic biomarker.
  • SALL4 plays a critical role in lung cancer cell proliferation and survival.
  • SALL4 represents a promising therapeutic target for lung cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...